REGN

Regeneron Pharmaceuticals, Inc.NASDAQHealthcare

$761.85-1.98%ClosedMarket Cap: $79.16B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	Truist Securities	—	Buy	—
2026-03-02	RBC Capital	—	Sector Perform	—
2026-02-09	Guggenheim	—	Buy	—
2026-02-02	Morgan Stanley	—	Equal Weight	—
2026-02-02	JP Morgan	—	Overweight	—
2026-02-02	Truist Securities	—	Buy	—
2026-02-02	Cantor Fitzgerald	—	Overweight	—
2026-02-02	Wells Fargo	—	Equal Weight	—
2026-02-02	Oppenheimer	—	Outperform	—
2026-01-22	Evercore ISI Group	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$52.94	$17.32B	8
Sun Dec 31	$60.83	$18.70B	8
Mon Dec 31	$67.38	$20.18B	6
Tue Dec 31	$71.97	$21.24B	6